MedPath

The effect of intervention with darbepoetin alfa on progression of renal decline[chronic renal failure?] in renal anaemia patients with chronic kidney disease not on dialysis.

Not Applicable
Conditions
renal anaemia patients with chronic kidney disease not on dialysis
Registration Number
JPRN-UMIN000006963
Lead Sponsor
Division of Nephrology,Department of Internal Medicine,Juntendo University Faculty of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

*Patient without renal anemia *Patient having hypersensitivity to rHuEPO. *Level of Hb is more than 13g/dL *Patients with anemia caused by conditions other than renal anemia such as GI bleeding and blood desease *Patients with serious allergies or serious drug sensitivities *Patients with severe complications *Pregnant or possibly pregnant and lactaing women *Ineligible patients according to the investigator's judgment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath